Skip to main content
Caplight Logo









MedFluid Co., Ltd.

MedFluid Co., Ltd.

Private
TaiwanHealthcare & Life Scienceshttps://medfluid.com.tw/

Last Round

Early Funding

May 12, 2023

Total Funding Raised

$160,000

Company Overview

MedFluid Co., Ltd. is a biotechnology company that develops automated microfluidic platforms for rapid infectious disease detection and personalized antibiotic susceptibility testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

microfluidicsantimicrobial susceptibility testingASTpoint-of-care testingPOCTveterinary diagnosticslab-on-a-chipdiagnostic instrumentationmolecular diagnosticsrazor-and-blade modelmicrofluidic cartridgesODM servicesOEM servicesCDMOinfectious disease detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedFluid Co., Ltd. Comparables

Compare MedFluid Co., Ltd. with similar companies based on industry and business-model similarity.

MedFluid Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Resistell AG
73%
Thermo Fisher Scientific Inc.
71%
Winnoz Technology
71%

MedFluid Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 12, 2023
AcceleratorMay 1, 2023
GrantMay 29, 2019

Key People

Founding team and executive leadership

Yulin Chou

Chief Medical Officer (CMO), Co-Founder

Founding Team

Bon Lee

CEO & Founder

Founding Team

MedFluid Co., Ltd. Investors

Notable investors and investment history

MedFluid Co., Ltd. investors
InvestorRounds
SparkLabs TaiwanAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 243% MoM.

  • Oct 15, 2025

    Grew 133% QoQ, from 3 to 7 employees.

MedFluid Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

MedFluid Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MedFluid Co., Ltd.'s valuation, stock price, and market status.

Is MedFluid Co., Ltd. a public or private company?

MedFluid Co., Ltd. is a private company.

What is the current stock price of MedFluid Co., Ltd.?

MedFluid Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is MedFluid Co., Ltd. worth (valuation)?

Valuation information for MedFluid Co., Ltd. is not publicly available.

Can I buy MedFluid Co., Ltd. stock?

MedFluid Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MedFluid Co., Ltd.'s last funding round?

MedFluid Co., Ltd.'s most recent funding round was Early Funding on May 12, 2023.

Who are the main investors in MedFluid Co., Ltd.?

Key investors in MedFluid Co., Ltd. include SparkLabs Taiwan.

Will MedFluid Co., Ltd. IPO soon?

No public IPO plans have been announced for MedFluid Co., Ltd..

How can I track MedFluid Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MedFluid Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaiwan
Employee Range6
Year Founded2019
Last FundingMay 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?